Archives of Clinical Infectious Diseases

Published by: Kowsar

Microbiological and Minimum Inhibitory Concentration Study of Ventilator-associated Pneumonia Agents in Two University-associated Hospital Intensive Care Units in Mazandaran

Ahmad Alikhani 1 , Narges Najafi 1 , * , Alireza Davoudi 1 , Samaneh Tiroum 2 , Mohammad Reza Khademloo 3 , Mohammad Ebrahim Tayyebi 1 , Arman Shoujaiifar 4 and Mahmood Doudangeh 4
Authors Information
1 Department of Infectious Diseases, Antimicrobial Resistant Research Center, Mazandaran University of Medical Sciences, Sari, IR Iran
2 Mazandaran University of Medical Sciences, Sari, IR Iran
3 Department of Social Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran
4 Laboratory of Microbiology, Mazandaran University of Medical Sciences, Sari, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: December 24, 2012, 8 (1); 8-13
  • Published Online: December 24, 2012
  • Article Type: Research Article
  • Received: September 24, 2012
  • Revised: October 8, 2012
  • Accepted: November 5, 2012
  • DOI: 10.5812/archcid.16034

To Cite: Alikhani A, Najafi N, Davoudi A, Tiroum S, Khademloo M R, et al. Microbiological and Minimum Inhibitory Concentration Study of Ventilator-associated Pneumonia Agents in Two University-associated Hospital Intensive Care Units in Mazandaran, Arch Clin Infect Dis. 2012 ; 8(1):8-13. doi: 10.5812/archcid.16034.

Abstract
Copyright © 2012, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Kollef MH. What is ventilator-associated pneumonia and why is it important? Respir Care. 2005; 50(6): 714-21[PubMed]
  • 2. Rello J, Diaz E. Pneumonia in the intensive care unit. Crit Care Med. 2003; 31(10): 2544-51[DOI][PubMed]
  • 3. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171(4): 388-416[DOI][PubMed]
  • 4. Coffin SE, Klompas M, Classen D, Arias KM, Podgorny K, Anderson DJ, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol. 2008; 29-40[DOI][PubMed]
  • 5. Craven DE. Preventing ventilator-associated pneumonia in adults: sowing seeds of change. Chest. 2006; 130(1): 251-60[DOI][PubMed]
  • 6. Dodek P, Keenan S, Cook D, Heyland D, Jacka M, Hand L, et al. Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med. 2004; 141(4): 305-13[PubMed]
  • 7. Hess DR, Kallstrom TJ, Mottram CD, Myers TR, Sorenson HM, Vines DL, et al. Care of the ventilator circuit and its relation to ventilator-associated pneumonia. Respir Care. 2003; 48(9): 869-79[PubMed]
  • 8. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R, CDC , Healthcare Infection Control Practices Advisory Committee , et al. Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2004; 53: 1-36[PubMed]
  • 9. Craven DE, Steger KA. Hospital-acquired pneumonia: perspectives for the healthcare epidemiologist. Infect Control Hosp Epidemiol. 1997; 18(11): 783-95[PubMed]
  • 10. Mayhall CG. Nosocomial pneumonia: diagnosis and prevention. Infect dis clin N Am. 1997; 11(2): 427-57
  • 11. Bonten MJM, Bergmans DCJJ. Hospital Epidemiology and Infection Control. 1999; : 211–38
  • 12. Wu CL, Yang DIe, Wang NY, Kuo HT, Chen PZ. Quantitative culture of endotracheal aspirates in the diagnosis of ventilator-associated pneumonia in patients with treatment failure. Chest. 2002; 122(2): 662-8[PubMed]
  • 13. Heyland DK, Cook DJ, Marshall J, Heule M, Guslits B, Lang J, et al. The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Canadian Critical Care Trials Group. Chest. 1999; 115(4): 1076-84[PubMed]
  • 14. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Internal Med. 2001; 134(4): 298-314
  • 15. Strausbaugh LJ. Principles and practice of infectious diseases. 2005; : 3363
  • 16. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000; 162(2 Pt 1): 505-11[DOI][PubMed]
  • 17. EUCAST Steering Committee Meeting 3-4 April 2007;
  • 18. Augustyn B. Ventilator-associated pneumonia: risk factors and prevention. Crit Care Nurse. 2007; 27(4): 32-9[PubMed]
  • 19. van Nieuwenhoven CA, Buskens E, Bergmans DC, van Tiel FH, Ramsay G, Bonten MJ. Oral decontamination is cost-saving in the prevention of ventilator-associated pneumonia in intensive care units. Crit Care Med. 2004; 32(1): 126-30[DOI][PubMed]
  • 20. Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stephan F, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med. 2000; 132(8): 621-30[PubMed]
  • 21. Kollef MH, Morrow LE, Niederman MS, Leeper KV, Anzueto A, Benz-Scott L, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest. 2006; 129(5): 1210-8[DOI][PubMed]
  • 22. Barclay L, Vega C. Ventilator-associated Pneumonia linked to worse outcomes in critically ill children. Pediatrics. 2009;; 123: 1108–15
  • 23. Lambiase A, Rossano F, Piazza O, Del Pezzo M, Catania MR, Tufano R. Typing of Pseudomonas aeruginosa isolated from patients with VAP in an intensive care unit. New Microbiol. 2009; 32(3): 277-83[PubMed]
  • 24. Wang G, Hindler JF, Ward KW, Bruckner DA. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol. 2006; 44(11): 3883-6[DOI][PubMed]
  • 25. Japoni A, Vazin A, Davarpanah MA, Afkhami Ardakani M, Alborzi A, Japoni S, et al. Ventilator-associated pneumonia in Iranian intensive care units. J Infect Dev Ctries. 2011; 5(4): 286-93[PubMed]
  • 26. Haque NZ, Zuniga LC, Peyrani P, Reyes K, Lamerato L, Moore CL, et al. Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia. Chest. 2010; 138(6): 1356-62[DOI][PubMed]
  • 27. de Carvalho RH, Gontijo Filho PP. Epidemiologically relevant antimicrobial resistance phenotypes in pathogens isolated from critically ill patients in a Brazilian Universitary Hospital. Braz J Microbiol. 2008; 39(4): 623-30[DOI][PubMed]
  • 28. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004; 32(8): 470-85[DOI][PubMed]
  • 29. Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD. Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection. 2003; 31(4): 208-15[PubMed]
  • 30. Laboratory detection of imipenem or meropenem resistance in gram-negative organisms.
  • 31. Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP, et al. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother. 2007; 51(4): 1553-5[DOI][PubMed]
  • 32. Sader HS, Jones RN, Gales AC, Silva JB, Pignatari AC. SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001. Braz J Infect Dis. 2004; 8(1): 25-79[PubMed]
  • 33. Mendes C, Oplustil C, Sakagami E, Turner P, Kiffer C. Antimicrobial susceptibility in intensive care units: MYSTIC program Brazil 2002. Braz J Infect Dis. 2005; 9(1): 44-51[PubMed]
  • 34. European Antimicrobial Resistance Surveillance System annual report. 2008;
  • 35. Harris AD, McGregor JC, Johnson JA, Strauss SM, Moore AC, Standiford HC, et al. Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis. 2007; 13(8): 1144-9[DOI][PubMed]
  • 36. Meyer E, Serr A, Schneider C, Utzolino S, Kern WV, Scholz R, et al. Should we screen patients for extended-spectrum beta-lactamase-producing enterobacteriaceae in intensive care units? Infect Control Hosp Epidemiol. 2009; 30(1): 103-5[DOI][PubMed]
  • 37. Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol. 2004; 42(3): 1089-94[PubMed]
  • 38. Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care. 2010; 14(3)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments